Work

Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough? – Authors' reply

Year: 2017

Type: letter

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(17)30640-x

Authors: Michael A Davies, Philippe Saiag, Georgina V Long

Institutions: The University of Texas MD Anderson Cancer Center, Assistance Publique – Hôpitaux de Paris, Hôpital Ambroise-Paré, The University of Sydney, Royal North Shore Hospital, Melanoma Institute Australia

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2753627940

Cites: 5

Cited by: 3

Related to: 10